We're unable to sign you in at this time. Please try again in a few minutes.
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
Comment & Response |

Intra-arterial Chemotherapy for Retinoblastoma ONLINE FIRST

Carol L. Shields, MD1; Jerry A. Shields, MD1
[+] Author Affiliations
1Ocular Oncology Service, Wills Eye Hospital, Thomas Jefferson University, Philadelphia, Pennsylvania
JAMA Ophthalmol. Published online August 11, 2016. doi:10.1001/jamaophthalmol.2016.2712
Text Size: A A A
Published online


To the Editor We acknowledge the time and effort of Yousef et al1 in their review of intra-arterial chemotherapy (IAC) for retinoblastoma. We agree with many of their thoughts including the abstract’s conclusion, “Intra-arterial chemotherapy is a promising new treatment associated with high rates of globe salvage,”1 and the article’s final phrase, “the authors recommend that IAC be offered selectively among other options, with fully informed discussion about all possible risks, benefits, and uncertainties.”1 The term selectively cannot be underestimated. The ocular oncologist must understand each therapeutic alternative and expected outcomes, such as when it is best to save the eye or advise enucleation, when it is safer to use intravenous chemotherapy (IVC) rather than IAC, and what the anticipated local and systemic effects are.2


Sign in

Purchase Options

• Buy this article
• Subscribe to the journal
• Rent this article ?

First Page Preview

View Large
First page PDF preview





August 11, 2016
David H. Abramson, MD; Brian P. Marr, MD; Jasmine H. Francis, MD
1Memorial Sloan-Kettering Cancer Center, New York, New York
JAMA Ophthalmol. Published online August 11, 2016.;():. doi:10.1001/jamaophthalmol.2016.2714.
August 11, 2016
Guillermo Chantada, MD, PhD; Paula Schaiquevich, PhD
1Hemato-Oncology Service, Hospital JP Garrahan, Buenos Aires, Argentina
2National Scientific and Technical Research Council, Buenos Aires, Argentina
JAMA Ophthalmol. Published online August 11, 2016.;():. doi:10.1001/jamaophthalmol.2016.2724.
August 11, 2016
Sameh E. Soliman, MD; Brenda L. Gallie, MD; Furqan Shaikh, MD
1Retinoblastoma Program, The Hospital for Sick Children, Toronto, Ontario, Canada
JAMA Ophthalmol. Published online August 11, 2016.;():. doi:10.1001/jamaophthalmol.2016.2759.
Also Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
Please click the checkbox indicating that you have read the full article in order to submit your answers.
Your answers have been saved for later.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.


Some tools below are only available to our subscribers or users with an online account.

0 Citations

Sign in

Purchase Options

• Buy this article
• Subscribe to the journal
• Rent this article ?

Related Content

Customize your page view by dragging & repositioning the boxes below.

See Also...